Your browser doesn't support javascript.
loading
Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure.
Breitkreutz, I; Heiss, C; Perne, A; Beimler, J; Jäger, D; Egerer, G; Ho, A D; Neben, K; Zeier, M; Goldschmidt, H; Raab, M S.
Afiliação
  • Breitkreutz I; 1] Max-Eder-Group 'Experimental Therapies for Hematologic Malignancies', Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany [2] Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg, Germany.
  • Heiss C; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Perne A; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Beimler J; Division of Nephrology, Heidelberg University Hospital, Heidelberg, Germany.
  • Jäger D; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg, Germany.
  • Egerer G; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Ho AD; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Neben K; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Zeier M; Division of Nephrology, Heidelberg University Hospital, Heidelberg, Germany.
  • Goldschmidt H; 1] Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg, Germany [2] Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Raab MS; 1] Max-Eder-Group 'Experimental Therapies for Hematologic Malignancies', Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany [2] Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
Bone Marrow Transplant ; 49(11): 1371-5, 2014 Nov.
Article em En | MEDLINE | ID: mdl-25089594

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinas / Ácidos Borônicos / Condicionamento Pré-Transplante / Transplante de Células-Tronco / Falência Renal Crônica / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Observational_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinas / Ácidos Borônicos / Condicionamento Pré-Transplante / Transplante de Células-Tronco / Falência Renal Crônica / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Observational_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Alemanha